Eli Lilly and Company
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 16.1T 14.2T 11.6T 12.4T
Cost of revenue 2.7T 2.2T 2.0T 2.2T
Gross profit 13.3T 12.0T 9.6T 10.2T
Operating expense
Research & development 3.2T 3.0T 2.5T 2.8T
Selling general and admin 2.4T 2.4T 2.2T 2.1T
Other operating expenses
Operating income 7.8T 6.5T 4.9T 5.3T
Non operating interest income
Income 59.4B 36.6B 44.1B 40.5B
Expense 164.1B 227.6B 222.7B 205.3B
Other income expense -1.1T -128.7B -1.6T -528.9B
Pretax income 6.6T 6.2T 3.2T 4.6T
Tax provision 1.5T 1.0T 636.8B 574.7B
Net income 5.1T 5.2T 2.5T 4.0T
Basic EPS 6.2 6.3 3.1 4.9
Diluted EPS 6.3 3.1 4.9
Basic average shares 818.7B 820.6B 820.4B 820.2B
Diluted average shares 821.4B 822.3B 823.0B 825.4B
EBITDA 8.1T 6.9T 5.4T 5.8T
Net income from continuing op. 5.1T 5.2T 2.5T 4.0T
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 5 hours 21 minutes

04:08
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).